Please use this identifier to cite or link to this item: http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5029
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUDDIN, ASLAMen_US
dc.contributor.authorROY, BIBHISANen_US
dc.contributor.authorJOSE, GREGOR P.en_US
dc.contributor.authorHossain, Saddam S. K.en_US
dc.contributor.authorHAZRA, PARTHAen_US
dc.date.accessioned2020-09-08T10:26:10Z
dc.date.available2020-09-08T10:26:10Z
dc.date.issued2020-08en_US
dc.identifier.citationNanoscale, 12(32), 16805-16818.en_US
dc.identifier.issn2040-3372en_US
dc.identifier.urihttp://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5029-
dc.identifier.urihttps://doi.org/10.1039/D0NR04312Een_US
dc.description.abstractAbnormal aggregation of amyloidogenic proteins (like Aβ 42, amylin, α-synuclein, insulin) and the deposition of these aggregates is believed to be associated with several diseases known as amyloidosis. The pathway of aggregation involves three distinct phases: the oligomeric, elongation and plateau phases. Among them, the oligomeric phase of Aβ 42 and α-synuclein involves the generation of transient oligomeric species suspected to cause several neurological disorders, including Alzheimer’s and Parkinson’s diseases. Over the past few years, scientists have devoted much more effort to devising new fluorescent molecular probes to estimate the mechanisms of formation, and have gained vital information about possible therapeutic routes for amyloidosis. However, such fluorescent probes face serious limitations because of self-quenching at high concentrations of the probe; therefore, they are inappropriate for quantitative analysis and bio-imaging experiments. Hence, smart biocompatible fluorescent probes are indispensable, as they not only overcome the drawbacks of conventional fluorescent probes, but also have the potential ability to fight amyloidosis through modulation of the pathways involved. In this work, for the first time we introduce a series of promising photo-switchable aggregation-induced emission (AIE) dots (DPAPMI, CPMI) and aggregation caused quenching (ACQ) dots (DMAPMI) which can detect amyloid fibrils in terms of switching and enhancing their fluorescence emission. Interestingly, the organic dots enhance the aggregation rate of insulin by speeding up the microscopic processes, specifically secondary nucleation (with rate constant k2) and the elongation process (with rate constant k+). Moreover, the comparison of kinetics studies with ThT suggests that our organic dots can sense pre-fibrillar aggregates of insulin during the aggregation process, which may be beneficial for the early detection of amyloid fibrils. In summary, our study indicates that these organic dots can be used for the imaging and early stage detection of amyloid fibril formation and the modulation of amyloid formation pathways.en_US
dc.language.isoenen_US
dc.publisherRoyal Society of Chemistryen_US
dc.subjectChemistryen_US
dc.subjectBiologyen_US
dc.subject2020en_US
dc.subject2020-SEP-WEEK1en_US
dc.subjectTOC-SEP-2020en_US
dc.titleSensing and modulation of amyloid fibrils by photo-switchable organic dotsen_US
dc.typeArticleen_US
dc.contributor.departmentDept. of Biologyen_US
dc.contributor.departmentDept. of Chemistryen_US
dc.identifier.sourcetitleNanoscaleen_US
dc.publication.originofpublisherForeignen_US
Appears in Collections:JOURNAL ARTICLES

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.